BacMam-Enabled LanthaScreen® Cellular Assays for PI3K/Akt Pathway Compound Profiling in Disease-Relevant Cell Backgrounds
Authors:
- Coby B. CarlsonCCCoby B. Carlson
- Michael J. MashockMMMichael J. Mashock
- Kun BiKBKun Bi
Open Access
- 1 March 2010
- journal article
- research article
- Published by Elsevier in SLAS Discovery
- Vol. 15 (3) , 327-334
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Characterization of serotonin 5-hydroxytryptamine-1A receptor activation using a phospho-extracellular-signal regulated kinase 2 sensorAnalytical Biochemistry, 2009
- PRAS40: Target or modulator of mTORC1 signalling and insulin action?Archives of Physiology and Biochemistry, 2009
- Development of LanthaScreen™ Cellular Assays for Key Components within the PI3K/AKT/mTOR PathwaySLAS Discovery, 2009
- Drug discovery approaches targeting the PI3K/Akt pathway in cancerOncogene, 2008
- Cellular LanthaScreen and β -Lactamase Reporter Assays for High-Throughput Screening of JAK2 InhibitorsASSAY and Drug Development Technologies, 2008
- High-throughput cellular assays for regulated posttranslational modificationsAnalytical Biochemistry, 2008
- BacMam technology and its application to drug discoveryExpert Opinion on Drug Discovery, 2007
- Evidence for functional redundancy of class IA PI3K isoforms in insulin signallingBiochemical Journal, 2007
- Implementation of BacMam virus gene delivery technology in a drug discovery settingDrug Discovery Today, 2007
- Transient and stable gene expression in mammalian cells transduced with a recombinant baculovirus vectorProceedings of the National Academy of Sciences, 1999